Advanced Healthcare Materials · 2022 · 57 citations · 35 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor MicroenvironmentCancer ImmunotherapyPhotodynamic TherapyTumor Immune MicroenvironmentTumor Microenvironment InteractionsTumor Microenvironment ModulationAcidic Tumor MicroenvironmentCancer Immunotherapy NanoparticlesCancer Photodynamic TherapyImmunosuppressive MicroenvironmentPhotodynamic Therapy NanomaterialsPhotodynamic Therapy-induced Immunogenic Cell DeathPyroptosis MechanismsTumor Microenvironment Regulation
Cancer immunotherapy is restricted to immune resistance caused by immunosuppressive tumor microenvironment. Pyroptosis involved in antitumor immunotherapy as a new schedule is prospective to reverse immunosuppression. Herein, acidic tumor microenvironment (TME)-evoked MRC nanoparticles (MRC NPs) co-delivering immune agonist RGX-104 and photosensitizer chlorine e6 (Ce6) are reported for pyroptosis-mediated immunotherapy. RGX-104 remodels TME by transcriptional activation of ApoE to regress myeloid-derived suppressor cells' (MDSCs) activity, which neatly creates foreshadowing for intensifying pyroptosis. Considering Ce6-triggered photodynamic therapy (PDT) can strengthen oxidative stress and organelles destruction to increase immunogenicity, immunomodulatory-photodynamic MRC nanodrugs will implement an aforementioned two-pronged strategy to enhance gasdermin E (GSDME)-dependent pyroptosis. RNA-seq analysis of MRC at the cellular level is introduced to first elucidate the intimate relationship between RGX-104 acting on LXR/ApoE axis and pyroptosis, where RGX-104 provides the prerequisite for pyroptosis participating in antitumor therapy. Briefly, MRC with favorable biocompatibility tackles the obstacle of hydrophobic drugs delivery, and becomes a powerful pyroptosis inducer to reinforce immune efficacy. MRC-elicited pyroptosis in combination with anti-PD-1 blockade therapy boosts immune response in solid tumors, successfully arresting invasive metastasis and extending survival based on remarkable antitumor immunity. MRC may initiate a new window for immuno-photo pyroptosis stimulators augmenting pyroptosis-based immunotherapy.
35
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Yupeng Wang, Wenqing Gao, Xuyan Shi et al. · Nature · 2017 · 3.2K citations
Ferroptosis as a target for protection against cardiomyopathy
Xuexian Fang, Hao Wang, Dan Han et al. · Proceedings of the National Academy of Sciences · 2019 · 2.1K citations · Full text
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhibin Zhang, Ying Zhang, Shiyu Xia et al. · Nature · 2020 · 1.7K citations · Full text
Medicine, Immunology, Oncology +16
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min, Kyle C. Roche, Shaomin Tian et al. · Nature Nanotechnology · 2017 · 689 citations
Life Sciences, Immunology, Oncology +16
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Masoud Tavazoie, Ilana Pollack, Raissa Tanqueco et al. · Cell · 2018 · 481 citations · Full text
Life Sciences, Immunology, Oncology +10